nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—hematologic cancer	0.307	1	CbGaD
Fidaxomicin—ABCB1—Lenalidomide—hematologic cancer	0.0665	0.141	CbGbCtD
Fidaxomicin—ABCB1—Daunorubicin—hematologic cancer	0.039	0.0826	CbGbCtD
Fidaxomicin—ABCB1—Alitretinoin—hematologic cancer	0.0382	0.0809	CbGbCtD
Fidaxomicin—ABCB1—Imatinib—hematologic cancer	0.0298	0.0633	CbGbCtD
Fidaxomicin—ABCB1—Nilotinib—hematologic cancer	0.0271	0.0575	CbGbCtD
Fidaxomicin—ABCB1—Vinorelbine—hematologic cancer	0.0269	0.057	CbGbCtD
Fidaxomicin—ABCB1—Dasatinib—hematologic cancer	0.024	0.0508	CbGbCtD
Fidaxomicin—ABCB1—Mitoxantrone—hematologic cancer	0.0237	0.0502	CbGbCtD
Fidaxomicin—ABCB1—Betamethasone—hematologic cancer	0.0211	0.0448	CbGbCtD
Fidaxomicin—ABCB1—Gemcitabine—hematologic cancer	0.0209	0.0444	CbGbCtD
Fidaxomicin—ABCB1—Prednisolone—hematologic cancer	0.0208	0.0442	CbGbCtD
Fidaxomicin—ABCB1—Prednisone—hematologic cancer	0.0197	0.0417	CbGbCtD
Fidaxomicin—ABCB1—Irinotecan—hematologic cancer	0.0186	0.0395	CbGbCtD
Fidaxomicin—ABCB1—Vinblastine—hematologic cancer	0.0166	0.0351	CbGbCtD
Fidaxomicin—ABCB1—Vincristine—hematologic cancer	0.0163	0.0346	CbGbCtD
Fidaxomicin—ABCB1—Cisplatin—hematologic cancer	0.0152	0.0322	CbGbCtD
Fidaxomicin—ABCB1—Etoposide—hematologic cancer	0.0149	0.0317	CbGbCtD
Fidaxomicin—ABCB1—Dexamethasone—hematologic cancer	0.0123	0.026	CbGbCtD
Fidaxomicin—ABCB1—Doxorubicin—hematologic cancer	0.0102	0.0216	CbGbCtD
Fidaxomicin—ABCB1—Methotrexate—hematologic cancer	0.00986	0.0209	CbGbCtD
Fidaxomicin—ABCB1—Abacavir transmembrane transport—SLC22A1—hematologic cancer	0.000834	0.0621	CbGpPWpGaD
Fidaxomicin—ABCB1—Abacavir transmembrane transport—ABCG2—hematologic cancer	0.000743	0.0553	CbGpPWpGaD
Fidaxomicin—ABCB1—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	0.000626	0.0466	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM2—hematologic cancer	0.000615	0.0458	CbGpPWpGaD
Fidaxomicin—ABCB1—Codeine and Morphine Metabolism—UGT1A1—hematologic cancer	0.000588	0.0438	CbGpPWpGaD
Fidaxomicin—ABCB1—Abacavir transport and metabolism—SLC22A1—hematologic cancer	0.000479	0.0356	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYL1—hematologic cancer	0.000466	0.0347	CbGpPWpGaD
Fidaxomicin—ABCB1—Abacavir transport and metabolism—ABCG2—hematologic cancer	0.000427	0.0318	CbGpPWpGaD
Fidaxomicin—ABCB1—Drug Induction of Bile Acid Pathway—ABCC3—hematologic cancer	0.000342	0.0255	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—NSD1—hematologic cancer	0.000301	0.0224	CbGpPWpGaD
Fidaxomicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.000249	0.0185	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCR—hematologic cancer	0.000245	0.0182	CbGpPWpGaD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.000206	0.0154	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—BNIP3—hematologic cancer	0.000201	0.015	CbGpPWpGaD
Fidaxomicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.000197	0.0146	CbGpPWpGaD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	0.000194	0.0145	CbGpPWpGaD
Fidaxomicin—ABCB1—ABC-family proteins mediated transport—ABCC3—hematologic cancer	0.000188	0.014	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—GATA2—hematologic cancer	0.000186	0.0138	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—hematologic cancer	0.000173	0.0129	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—ID2—hematologic cancer	0.00016	0.0119	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PPP1R13L—hematologic cancer	0.000157	0.0117	CbGpPWpGaD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000152	0.0113	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—MCL1—hematologic cancer	0.000136	0.0101	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—hematologic cancer	0.000133	0.00991	CbGpPWpGaD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000125	0.00931	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—CA9—hematologic cancer	0.000124	0.00926	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CXCR5—hematologic cancer	0.000122	0.00908	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—hematologic cancer	0.00012	0.00891	CbGpPWpGaD
Fidaxomicin—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000114	0.000546	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000114	0.000546	CcSEcCtD
Fidaxomicin—Abdominal pain—Vincristine—hematologic cancer	0.000113	0.000542	CcSEcCtD
Fidaxomicin—Dyspnoea—Cisplatin—hematologic cancer	0.000113	0.000541	CcSEcCtD
Fidaxomicin—Skin disorder—Etoposide—hematologic cancer	0.000112	0.00054	CcSEcCtD
Fidaxomicin—Dizziness—Vinorelbine—hematologic cancer	0.000112	0.000536	CcSEcCtD
Fidaxomicin—Nausea—Lenalidomide—hematologic cancer	0.000112	0.000535	CcSEcCtD
Fidaxomicin—Hypersensitivity—Carmustine—hematologic cancer	0.00011	0.000529	CcSEcCtD
Fidaxomicin—Pruritus—Thalidomide—hematologic cancer	0.00011	0.000529	CcSEcCtD
Fidaxomicin—Abdominal pain—Mitoxantrone—hematologic cancer	0.00011	0.000528	CcSEcCtD
Fidaxomicin—Abdominal pain—Irinotecan—hematologic cancer	0.00011	0.000528	CcSEcCtD
Fidaxomicin—Nausea—Hydroxyurea—hematologic cancer	0.00011	0.000528	CcSEcCtD
Fidaxomicin—Vomiting—Bortezomib—hematologic cancer	0.00011	0.000527	CcSEcCtD
Fidaxomicin—Decreased appetite—Cisplatin—hematologic cancer	0.00011	0.000527	CcSEcCtD
Fidaxomicin—Hypersensitivity—Alitretinoin—hematologic cancer	0.000109	0.000524	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000109	0.000524	CcSEcCtD
Fidaxomicin—Vomiting—Bleomycin—hematologic cancer	0.000109	0.000523	CcSEcCtD
Fidaxomicin—Rash—Bortezomib—hematologic cancer	0.000109	0.000523	CcSEcCtD
Fidaxomicin—Dermatitis—Bortezomib—hematologic cancer	0.000109	0.000523	CcSEcCtD
Fidaxomicin—Headache—Bortezomib—hematologic cancer	0.000108	0.00052	CcSEcCtD
Fidaxomicin—Rash—Bleomycin—hematologic cancer	0.000108	0.000519	CcSEcCtD
Fidaxomicin—Dermatitis—Bleomycin—hematologic cancer	0.000108	0.000519	CcSEcCtD
Fidaxomicin—Hypersensitivity—Ifosfamide—hematologic cancer	0.000108	0.000518	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—CXCL13—hematologic cancer	0.000108	0.00802	CbGpPWpGaD
Fidaxomicin—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	0.000108	0.000517	CcSEcCtD
Fidaxomicin—Vomiting—Vinorelbine—hematologic cancer	0.000107	0.000515	CcSEcCtD
Fidaxomicin—Dry mouth—Triamcinolone—hematologic cancer	0.000107	0.000514	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—NPM1—hematologic cancer	0.000107	0.00795	CbGpPWpGaD
Fidaxomicin—Neutropenia—Epirubicin—hematologic cancer	0.000107	0.000512	CcSEcCtD
Fidaxomicin—Angioedema—Betamethasone—hematologic cancer	0.000107	0.000512	CcSEcCtD
Fidaxomicin—Angioedema—Dexamethasone—hematologic cancer	0.000107	0.000512	CcSEcCtD
Fidaxomicin—Dizziness—Thiotepa—hematologic cancer	0.000107	0.000512	CcSEcCtD
Fidaxomicin—Rash—Vinorelbine—hematologic cancer	0.000106	0.000511	CcSEcCtD
Fidaxomicin—Dermatitis—Vinorelbine—hematologic cancer	0.000106	0.00051	CcSEcCtD
Fidaxomicin—Abdominal distension—Doxorubicin—hematologic cancer	0.000106	0.00051	CcSEcCtD
Fidaxomicin—Headache—Vinorelbine—hematologic cancer	0.000106	0.000507	CcSEcCtD
Fidaxomicin—Dysphagia—Doxorubicin—hematologic cancer	0.000106	0.000507	CcSEcCtD
Fidaxomicin—Immune system disorder—Prednisone—hematologic cancer	0.000105	0.000506	CcSEcCtD
Fidaxomicin—Hypersensitivity—Vincristine—hematologic cancer	0.000105	0.000505	CcSEcCtD
Fidaxomicin—Pruritus—Alitretinoin—hematologic cancer	0.000105	0.000504	CcSEcCtD
Fidaxomicin—Pruritus—Ifosfamide—hematologic cancer	0.000104	0.000498	CcSEcCtD
Fidaxomicin—Dyspnoea—Etoposide—hematologic cancer	0.000103	0.000495	CcSEcCtD
Fidaxomicin—Dizziness—Thalidomide—hematologic cancer	0.000103	0.000495	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Epirubicin—hematologic cancer	0.000103	0.000494	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Methotrexate—hematologic cancer	0.000103	0.000494	CcSEcCtD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—hematologic cancer	0.000103	0.00764	CbGpPWpGaD
Fidaxomicin—Nausea—Bortezomib—hematologic cancer	0.000103	0.000493	CcSEcCtD
Fidaxomicin—Hypersensitivity—Irinotecan—hematologic cancer	0.000103	0.000492	CcSEcCtD
Fidaxomicin—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000103	0.000492	CcSEcCtD
Fidaxomicin—Vomiting—Thiotepa—hematologic cancer	0.000102	0.000492	CcSEcCtD
Fidaxomicin—Nausea—Bleomycin—hematologic cancer	0.000102	0.000489	CcSEcCtD
Fidaxomicin—Malnutrition—Prednisone—hematologic cancer	0.000102	0.000488	CcSEcCtD
Fidaxomicin—Rash—Thiotepa—hematologic cancer	0.000102	0.000488	CcSEcCtD
Fidaxomicin—Dermatitis—Thiotepa—hematologic cancer	0.000101	0.000487	CcSEcCtD
Fidaxomicin—Headache—Thiotepa—hematologic cancer	0.000101	0.000485	CcSEcCtD
Fidaxomicin—Decreased appetite—Etoposide—hematologic cancer	0.000101	0.000483	CcSEcCtD
Fidaxomicin—Nausea—Vinorelbine—hematologic cancer	0.0001	0.000481	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Etoposide—hematologic cancer	9.99e-05	0.00048	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	9.93e-05	0.0074	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—hematologic cancer	9.92e-05	0.00738	CbGpPWpGaD
Fidaxomicin—Vomiting—Thalidomide—hematologic cancer	9.91e-05	0.000476	CcSEcCtD
Fidaxomicin—Dizziness—Carmustine—hematologic cancer	9.9e-05	0.000475	CcSEcCtD
Fidaxomicin—Constipation—Etoposide—hematologic cancer	9.9e-05	0.000475	CcSEcCtD
Fidaxomicin—Neutropenia—Doxorubicin—hematologic cancer	9.87e-05	0.000474	CcSEcCtD
Fidaxomicin—Rash—Thalidomide—hematologic cancer	9.83e-05	0.000472	CcSEcCtD
Fidaxomicin—Dermatitis—Thalidomide—hematologic cancer	9.82e-05	0.000471	CcSEcCtD
Fidaxomicin—Dizziness—Alitretinoin—hematologic cancer	9.8e-05	0.000471	CcSEcCtD
Fidaxomicin—Headache—Thalidomide—hematologic cancer	9.76e-05	0.000469	CcSEcCtD
Fidaxomicin—Dizziness—Ifosfamide—hematologic cancer	9.69e-05	0.000465	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Epirubicin—hematologic cancer	9.62e-05	0.000462	CcSEcCtD
Fidaxomicin—Pruritus—Gemcitabine—hematologic cancer	9.59e-05	0.00046	CcSEcCtD
Fidaxomicin—Nausea—Thiotepa—hematologic cancer	9.57e-05	0.000459	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Doxorubicin—hematologic cancer	9.52e-05	0.000457	CcSEcCtD
Fidaxomicin—Vomiting—Carmustine—hematologic cancer	9.52e-05	0.000457	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Etoposide—hematologic cancer	9.46e-05	0.000454	CcSEcCtD
Fidaxomicin—Dizziness—Vincristine—hematologic cancer	9.45e-05	0.000454	CcSEcCtD
Fidaxomicin—Rash—Carmustine—hematologic cancer	9.44e-05	0.000453	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—ABCG2—hematologic cancer	9.43e-05	0.00702	CbGpPWpGaD
Fidaxomicin—Dermatitis—Carmustine—hematologic cancer	9.43e-05	0.000453	CcSEcCtD
Fidaxomicin—Vomiting—Alitretinoin—hematologic cancer	9.43e-05	0.000453	CcSEcCtD
Fidaxomicin—Anaemia—Prednisone—hematologic cancer	9.39e-05	0.000451	CcSEcCtD
Fidaxomicin—Headache—Carmustine—hematologic cancer	9.38e-05	0.00045	CcSEcCtD
Fidaxomicin—Dyspnoea—Triamcinolone—hematologic cancer	9.36e-05	0.000449	CcSEcCtD
Fidaxomicin—Rash—Alitretinoin—hematologic cancer	9.35e-05	0.000449	CcSEcCtD
Fidaxomicin—Nervous system disorder—Dexamethasone—hematologic cancer	9.34e-05	0.000448	CcSEcCtD
Fidaxomicin—Nervous system disorder—Betamethasone—hematologic cancer	9.34e-05	0.000448	CcSEcCtD
Fidaxomicin—Dermatitis—Alitretinoin—hematologic cancer	9.34e-05	0.000448	CcSEcCtD
Fidaxomicin—Vomiting—Ifosfamide—hematologic cancer	9.32e-05	0.000447	CcSEcCtD
Fidaxomicin—Hypersensitivity—Cisplatin—hematologic cancer	9.31e-05	0.000447	CcSEcCtD
Fidaxomicin—Headache—Alitretinoin—hematologic cancer	9.29e-05	0.000446	CcSEcCtD
Fidaxomicin—Angioedema—Prednisone—hematologic cancer	9.29e-05	0.000446	CcSEcCtD
Fidaxomicin—Nausea—Thalidomide—hematologic cancer	9.26e-05	0.000444	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—FOXP3—hematologic cancer	9.24e-05	0.00688	CbGpPWpGaD
Fidaxomicin—Dyspepsia—Triamcinolone—hematologic cancer	9.24e-05	0.000444	CcSEcCtD
Fidaxomicin—Rash—Ifosfamide—hematologic cancer	9.24e-05	0.000444	CcSEcCtD
Fidaxomicin—Dermatitis—Ifosfamide—hematologic cancer	9.23e-05	0.000443	CcSEcCtD
Fidaxomicin—Dizziness—Irinotecan—hematologic cancer	9.2e-05	0.000442	CcSEcCtD
Fidaxomicin—Abdominal pain—Etoposide—hematologic cancer	9.15e-05	0.000439	CcSEcCtD
Fidaxomicin—Vomiting—Vincristine—hematologic cancer	9.08e-05	0.000436	CcSEcCtD
Fidaxomicin—Rash—Vincristine—hematologic cancer	9.01e-05	0.000432	CcSEcCtD
Fidaxomicin—Dermatitis—Vincristine—hematologic cancer	9e-05	0.000432	CcSEcCtD
Fidaxomicin—Headache—Vincristine—hematologic cancer	8.95e-05	0.00043	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Doxorubicin—hematologic cancer	8.9e-05	0.000427	CcSEcCtD
Fidaxomicin—Nausea—Carmustine—hematologic cancer	8.89e-05	0.000427	CcSEcCtD
Fidaxomicin—Vomiting—Mitoxantrone—hematologic cancer	8.85e-05	0.000425	CcSEcCtD
Fidaxomicin—Vomiting—Irinotecan—hematologic cancer	8.85e-05	0.000425	CcSEcCtD
Fidaxomicin—Immune system disorder—Methotrexate—hematologic cancer	8.81e-05	0.000423	CcSEcCtD
Fidaxomicin—Nausea—Alitretinoin—hematologic cancer	8.81e-05	0.000423	CcSEcCtD
Fidaxomicin—Rash—Irinotecan—hematologic cancer	8.77e-05	0.000421	CcSEcCtD
Fidaxomicin—Rash—Mitoxantrone—hematologic cancer	8.77e-05	0.000421	CcSEcCtD
Fidaxomicin—Dermatitis—Irinotecan—hematologic cancer	8.77e-05	0.000421	CcSEcCtD
Fidaxomicin—Dermatitis—Mitoxantrone—hematologic cancer	8.77e-05	0.000421	CcSEcCtD
Fidaxomicin—Headache—Mitoxantrone—hematologic cancer	8.72e-05	0.000418	CcSEcCtD
Fidaxomicin—Headache—Irinotecan—hematologic cancer	8.72e-05	0.000418	CcSEcCtD
Fidaxomicin—Nausea—Ifosfamide—hematologic cancer	8.7e-05	0.000418	CcSEcCtD
Fidaxomicin—Vomiting—Gemcitabine—hematologic cancer	8.62e-05	0.000414	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	8.59e-05	0.000413	CcSEcCtD
Fidaxomicin—Rash—Gemcitabine—hematologic cancer	8.55e-05	0.00041	CcSEcCtD
Fidaxomicin—Dermatitis—Gemcitabine—hematologic cancer	8.54e-05	0.00041	CcSEcCtD
Fidaxomicin—Hypersensitivity—Etoposide—hematologic cancer	8.53e-05	0.000409	CcSEcCtD
Fidaxomicin—Malnutrition—Methotrexate—hematologic cancer	8.49e-05	0.000408	CcSEcCtD
Fidaxomicin—Headache—Gemcitabine—hematologic cancer	8.49e-05	0.000408	CcSEcCtD
Fidaxomicin—Nausea—Vincristine—hematologic cancer	8.49e-05	0.000407	CcSEcCtD
Fidaxomicin—Hypersensitivity—Prednisolone—hematologic cancer	8.41e-05	0.000404	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—TFRC—hematologic cancer	8.4e-05	0.00626	CbGpPWpGaD
Fidaxomicin—Dyspepsia—Betamethasone—hematologic cancer	8.38e-05	0.000403	CcSEcCtD
Fidaxomicin—Dyspepsia—Dexamethasone—hematologic cancer	8.38e-05	0.000403	CcSEcCtD
Fidaxomicin—Dysgeusia—Methotrexate—hematologic cancer	8.32e-05	0.000399	CcSEcCtD
Fidaxomicin—Decreased appetite—Dexamethasone—hematologic cancer	8.28e-05	0.000398	CcSEcCtD
Fidaxomicin—Decreased appetite—Betamethasone—hematologic cancer	8.28e-05	0.000398	CcSEcCtD
Fidaxomicin—Nausea—Mitoxantrone—hematologic cancer	8.26e-05	0.000397	CcSEcCtD
Fidaxomicin—Nausea—Irinotecan—hematologic cancer	8.26e-05	0.000397	CcSEcCtD
Fidaxomicin—Immune system disorder—Epirubicin—hematologic cancer	8.25e-05	0.000396	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	8.22e-05	0.000395	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Betamethasone—hematologic cancer	8.22e-05	0.000395	CcSEcCtD
Fidaxomicin—Pruritus—Etoposide—hematologic cancer	8.19e-05	0.000393	CcSEcCtD
Fidaxomicin—Nervous system disorder—Prednisone—hematologic cancer	8.13e-05	0.000391	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—EPO—hematologic cancer	8.09e-05	0.00602	CbGpPWpGaD
Fidaxomicin—Skin disorder—Prednisone—hematologic cancer	8.06e-05	0.000387	CcSEcCtD
Fidaxomicin—Nausea—Gemcitabine—hematologic cancer	8.05e-05	0.000387	CcSEcCtD
Fidaxomicin—Vomiting—Cisplatin—hematologic cancer	8.03e-05	0.000386	CcSEcCtD
Fidaxomicin—Rash—Cisplatin—hematologic cancer	7.97e-05	0.000382	CcSEcCtD
Fidaxomicin—Dermatitis—Cisplatin—hematologic cancer	7.96e-05	0.000382	CcSEcCtD
Fidaxomicin—Malnutrition—Epirubicin—hematologic cancer	7.95e-05	0.000382	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—IL13—hematologic cancer	7.91e-05	0.00589	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—GZMB—hematologic cancer	7.91e-05	0.00589	CbGpPWpGaD
Fidaxomicin—Anaemia—Methotrexate—hematologic cancer	7.85e-05	0.000377	CcSEcCtD
Fidaxomicin—Flatulence—Epirubicin—hematologic cancer	7.83e-05	0.000376	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Betamethasone—hematologic cancer	7.79e-05	0.000374	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.79e-05	0.000374	CcSEcCtD
Fidaxomicin—Dysgeusia—Epirubicin—hematologic cancer	7.78e-05	0.000374	CcSEcCtD
Fidaxomicin—Hypersensitivity—Triamcinolone—hematologic cancer	7.73e-05	0.000371	CcSEcCtD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—hematologic cancer	7.71e-05	0.00574	CbGpPWpGaD
Fidaxomicin—Dizziness—Etoposide—hematologic cancer	7.65e-05	0.000367	CcSEcCtD
Fidaxomicin—Immune system disorder—Doxorubicin—hematologic cancer	7.63e-05	0.000366	CcSEcCtD
Fidaxomicin—Dizziness—Prednisolone—hematologic cancer	7.55e-05	0.000362	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—CXCR4—hematologic cancer	7.54e-05	0.00561	CbGpPWpGaD
Fidaxomicin—Abdominal pain—Betamethasone—hematologic cancer	7.53e-05	0.000362	CcSEcCtD
Fidaxomicin—Abdominal pain—Dexamethasone—hematologic cancer	7.53e-05	0.000362	CcSEcCtD
Fidaxomicin—Nausea—Cisplatin—hematologic cancer	7.5e-05	0.00036	CcSEcCtD
Fidaxomicin—Pruritus—Triamcinolone—hematologic cancer	7.43e-05	0.000357	CcSEcCtD
Fidaxomicin—Vomiting—Etoposide—hematologic cancer	7.36e-05	0.000353	CcSEcCtD
Fidaxomicin—Malnutrition—Doxorubicin—hematologic cancer	7.36e-05	0.000353	CcSEcCtD
Fidaxomicin—Anaemia—Epirubicin—hematologic cancer	7.35e-05	0.000353	CcSEcCtD
Fidaxomicin—Dyspepsia—Prednisone—hematologic cancer	7.3e-05	0.000351	CcSEcCtD
Fidaxomicin—Rash—Etoposide—hematologic cancer	7.3e-05	0.00035	CcSEcCtD
Fidaxomicin—Dermatitis—Etoposide—hematologic cancer	7.29e-05	0.00035	CcSEcCtD
Fidaxomicin—Headache—Etoposide—hematologic cancer	7.25e-05	0.000348	CcSEcCtD
Fidaxomicin—Flatulence—Doxorubicin—hematologic cancer	7.25e-05	0.000348	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—CASP7—hematologic cancer	7.24e-05	0.00539	CbGpPWpGaD
Fidaxomicin—Decreased appetite—Prednisone—hematologic cancer	7.21e-05	0.000346	CcSEcCtD
Fidaxomicin—Dysgeusia—Doxorubicin—hematologic cancer	7.2e-05	0.000346	CcSEcCtD
Fidaxomicin—Rash—Prednisolone—hematologic cancer	7.2e-05	0.000346	CcSEcCtD
Fidaxomicin—Dermatitis—Prednisolone—hematologic cancer	7.19e-05	0.000345	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.18e-05	0.000345	CcSEcCtD
Fidaxomicin—Headache—Prednisolone—hematologic cancer	7.15e-05	0.000343	CcSEcCtD
Fidaxomicin—Constipation—Prednisone—hematologic cancer	7.09e-05	0.000341	CcSEcCtD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—hematologic cancer	7.05e-05	0.00525	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—hematologic cancer	7.02e-05	0.00522	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—PRKCZ—hematologic cancer	7.01e-05	0.00522	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—hematologic cancer	6.94e-05	0.00517	CbGpPWpGaD
Fidaxomicin—Dizziness—Triamcinolone—hematologic cancer	6.94e-05	0.000333	CcSEcCtD
Fidaxomicin—Nausea—Etoposide—hematologic cancer	6.87e-05	0.00033	CcSEcCtD
Fidaxomicin—Nervous system disorder—Methotrexate—hematologic cancer	6.8e-05	0.000326	CcSEcCtD
Fidaxomicin—Anaemia—Doxorubicin—hematologic cancer	6.8e-05	0.000326	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Prednisone—hematologic cancer	6.78e-05	0.000326	CcSEcCtD
Fidaxomicin—Nausea—Prednisolone—hematologic cancer	6.78e-05	0.000326	CcSEcCtD
Fidaxomicin—Pruritus—Betamethasone—hematologic cancer	6.74e-05	0.000324	CcSEcCtD
Fidaxomicin—Pruritus—Dexamethasone—hematologic cancer	6.74e-05	0.000324	CcSEcCtD
Fidaxomicin—Skin disorder—Methotrexate—hematologic cancer	6.73e-05	0.000323	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.72e-05	0.000323	CcSEcCtD
Fidaxomicin—Vomiting—Triamcinolone—hematologic cancer	6.67e-05	0.00032	CcSEcCtD
Fidaxomicin—Rash—Triamcinolone—hematologic cancer	6.62e-05	0.000318	CcSEcCtD
Fidaxomicin—Dry mouth—Epirubicin—hematologic cancer	6.62e-05	0.000318	CcSEcCtD
Fidaxomicin—Dermatitis—Triamcinolone—hematologic cancer	6.61e-05	0.000317	CcSEcCtD
Fidaxomicin—Headache—Triamcinolone—hematologic cancer	6.58e-05	0.000316	CcSEcCtD
Fidaxomicin—Abdominal pain—Prednisone—hematologic cancer	6.56e-05	0.000315	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—CD40—hematologic cancer	6.46e-05	0.00481	CbGpPWpGaD
Fidaxomicin—Nervous system disorder—Epirubicin—hematologic cancer	6.36e-05	0.000305	CcSEcCtD
Fidaxomicin—Skin disorder—Epirubicin—hematologic cancer	6.3e-05	0.000303	CcSEcCtD
Fidaxomicin—Dizziness—Dexamethasone—hematologic cancer	6.3e-05	0.000302	CcSEcCtD
Fidaxomicin—Dizziness—Betamethasone—hematologic cancer	6.3e-05	0.000302	CcSEcCtD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—hematologic cancer	6.25e-05	0.00466	CbGpPWpGaD
Fidaxomicin—Nausea—Triamcinolone—hematologic cancer	6.24e-05	0.000299	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.22e-05	0.000299	CcSEcCtD
Fidaxomicin—Dyspnoea—Methotrexate—hematologic cancer	6.18e-05	0.000297	CcSEcCtD
Fidaxomicin—Dry mouth—Doxorubicin—hematologic cancer	6.12e-05	0.000294	CcSEcCtD
Fidaxomicin—Hypersensitivity—Prednisone—hematologic cancer	6.11e-05	0.000293	CcSEcCtD
Fidaxomicin—Dyspepsia—Methotrexate—hematologic cancer	6.1e-05	0.000293	CcSEcCtD
Fidaxomicin—Vomiting—Betamethasone—hematologic cancer	6.06e-05	0.000291	CcSEcCtD
Fidaxomicin—Vomiting—Dexamethasone—hematologic cancer	6.06e-05	0.000291	CcSEcCtD
Fidaxomicin—Decreased appetite—Methotrexate—hematologic cancer	6.03e-05	0.000289	CcSEcCtD
Fidaxomicin—Rash—Betamethasone—hematologic cancer	6.01e-05	0.000288	CcSEcCtD
Fidaxomicin—Rash—Dexamethasone—hematologic cancer	6.01e-05	0.000288	CcSEcCtD
Fidaxomicin—Dermatitis—Betamethasone—hematologic cancer	6e-05	0.000288	CcSEcCtD
Fidaxomicin—Dermatitis—Dexamethasone—hematologic cancer	6e-05	0.000288	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.99e-05	0.000287	CcSEcCtD
Fidaxomicin—Headache—Dexamethasone—hematologic cancer	5.97e-05	0.000286	CcSEcCtD
Fidaxomicin—Headache—Betamethasone—hematologic cancer	5.97e-05	0.000286	CcSEcCtD
Fidaxomicin—Nervous system disorder—Doxorubicin—hematologic cancer	5.89e-05	0.000283	CcSEcCtD
Fidaxomicin—Pruritus—Prednisone—hematologic cancer	5.87e-05	0.000282	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—STAT1—hematologic cancer	5.85e-05	0.00436	CbGpPWpGaD
Fidaxomicin—Skin disorder—Doxorubicin—hematologic cancer	5.83e-05	0.00028	CcSEcCtD
Fidaxomicin—Dyspnoea—Epirubicin—hematologic cancer	5.78e-05	0.000278	CcSEcCtD
Fidaxomicin—Dyspepsia—Epirubicin—hematologic cancer	5.71e-05	0.000274	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Methotrexate—hematologic cancer	5.67e-05	0.000272	CcSEcCtD
Fidaxomicin—Nausea—Betamethasone—hematologic cancer	5.66e-05	0.000272	CcSEcCtD
Fidaxomicin—Nausea—Dexamethasone—hematologic cancer	5.66e-05	0.000272	CcSEcCtD
Fidaxomicin—Decreased appetite—Epirubicin—hematologic cancer	5.64e-05	0.000271	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—HLA-DQA1—hematologic cancer	5.6e-05	0.00417	CbGpPWpGaD
Fidaxomicin—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.6e-05	0.000269	CcSEcCtD
Fidaxomicin—Constipation—Epirubicin—hematologic cancer	5.55e-05	0.000266	CcSEcCtD
Fidaxomicin—Dizziness—Prednisone—hematologic cancer	5.49e-05	0.000263	CcSEcCtD
Fidaxomicin—Abdominal pain—Methotrexate—hematologic cancer	5.48e-05	0.000263	CcSEcCtD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—hematologic cancer	5.38e-05	0.00401	CbGpPWpGaD
Fidaxomicin—Dyspnoea—Doxorubicin—hematologic cancer	5.35e-05	0.000257	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Epirubicin—hematologic cancer	5.31e-05	0.000255	CcSEcCtD
Fidaxomicin—Dyspepsia—Doxorubicin—hematologic cancer	5.28e-05	0.000254	CcSEcCtD
Fidaxomicin—Vomiting—Prednisone—hematologic cancer	5.27e-05	0.000253	CcSEcCtD
Fidaxomicin—Rash—Prednisone—hematologic cancer	5.23e-05	0.000251	CcSEcCtD
Fidaxomicin—Dermatitis—Prednisone—hematologic cancer	5.23e-05	0.000251	CcSEcCtD
Fidaxomicin—Decreased appetite—Doxorubicin—hematologic cancer	5.22e-05	0.000251	CcSEcCtD
Fidaxomicin—Headache—Prednisone—hematologic cancer	5.2e-05	0.000249	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.18e-05	0.000249	CcSEcCtD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—hematologic cancer	5.18e-05	0.00386	CbGpPWpGaD
Fidaxomicin—Constipation—Doxorubicin—hematologic cancer	5.13e-05	0.000246	CcSEcCtD
Fidaxomicin—Abdominal pain—Epirubicin—hematologic cancer	5.13e-05	0.000246	CcSEcCtD
Fidaxomicin—Hypersensitivity—Methotrexate—hematologic cancer	5.11e-05	0.000245	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—CD86—hematologic cancer	5.05e-05	0.00376	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—TERT—hematologic cancer	5.03e-05	0.00375	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—IL10—hematologic cancer	4.95e-05	0.00368	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CD40LG—hematologic cancer	4.95e-05	0.00368	CbGpPWpGaD
Fidaxomicin—Nausea—Prednisone—hematologic cancer	4.93e-05	0.000237	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.91e-05	0.000236	CcSEcCtD
Fidaxomicin—Pruritus—Methotrexate—hematologic cancer	4.9e-05	0.000235	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—IL4—hematologic cancer	4.81e-05	0.00358	CbGpPWpGaD
Fidaxomicin—Hypersensitivity—Epirubicin—hematologic cancer	4.78e-05	0.000229	CcSEcCtD
Fidaxomicin—Abdominal pain—Doxorubicin—hematologic cancer	4.75e-05	0.000228	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—PDGFRA—hematologic cancer	4.74e-05	0.00353	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—HLA-B—hematologic cancer	4.71e-05	0.0035	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	4.65e-05	0.00346	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—FASLG—hematologic cancer	4.6e-05	0.00342	CbGpPWpGaD
Fidaxomicin—Pruritus—Epirubicin—hematologic cancer	4.59e-05	0.00022	CcSEcCtD
Fidaxomicin—Dizziness—Methotrexate—hematologic cancer	4.58e-05	0.00022	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—FAS—hematologic cancer	4.44e-05	0.0033	CbGpPWpGaD
Fidaxomicin—Hypersensitivity—Doxorubicin—hematologic cancer	4.42e-05	0.000212	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—IL2RA—hematologic cancer	4.41e-05	0.00328	CbGpPWpGaD
Fidaxomicin—Vomiting—Methotrexate—hematologic cancer	4.41e-05	0.000212	CcSEcCtD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	4.41e-05	0.00328	CbGpPWpGaD
Fidaxomicin—Rash—Methotrexate—hematologic cancer	4.37e-05	0.00021	CcSEcCtD
Fidaxomicin—Dermatitis—Methotrexate—hematologic cancer	4.37e-05	0.00021	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—HLA-A—hematologic cancer	4.36e-05	0.00325	CbGpPWpGaD
Fidaxomicin—Headache—Methotrexate—hematologic cancer	4.34e-05	0.000209	CcSEcCtD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—AQP9—hematologic cancer	4.32e-05	0.00322	CbGpPWpGaD
Fidaxomicin—Dizziness—Epirubicin—hematologic cancer	4.29e-05	0.000206	CcSEcCtD
Fidaxomicin—Pruritus—Doxorubicin—hematologic cancer	4.25e-05	0.000204	CcSEcCtD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	4.17e-05	0.00311	CbGpPWpGaD
Fidaxomicin—Vomiting—Epirubicin—hematologic cancer	4.12e-05	0.000198	CcSEcCtD
Fidaxomicin—Nausea—Methotrexate—hematologic cancer	4.12e-05	0.000198	CcSEcCtD
Fidaxomicin—Rash—Epirubicin—hematologic cancer	4.09e-05	0.000196	CcSEcCtD
Fidaxomicin—Dermatitis—Epirubicin—hematologic cancer	4.09e-05	0.000196	CcSEcCtD
Fidaxomicin—Headache—Epirubicin—hematologic cancer	4.06e-05	0.000195	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—FOS—hematologic cancer	4.04e-05	0.00301	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—CREB1—hematologic cancer	4.04e-05	0.00301	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	4.02e-05	0.00299	CbGpPWpGaD
Fidaxomicin—Dizziness—Doxorubicin—hematologic cancer	3.97e-05	0.000191	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—hematologic cancer	3.93e-05	0.00293	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	3.93e-05	0.00292	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	3.87e-05	0.00288	CbGpPWpGaD
Fidaxomicin—Nausea—Epirubicin—hematologic cancer	3.85e-05	0.000185	CcSEcCtD
Fidaxomicin—Vomiting—Doxorubicin—hematologic cancer	3.82e-05	0.000183	CcSEcCtD
Fidaxomicin—Rash—Doxorubicin—hematologic cancer	3.78e-05	0.000182	CcSEcCtD
Fidaxomicin—Dermatitis—Doxorubicin—hematologic cancer	3.78e-05	0.000182	CcSEcCtD
Fidaxomicin—Headache—Doxorubicin—hematologic cancer	3.76e-05	0.000181	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—CD80—hematologic cancer	3.68e-05	0.00274	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—hematologic cancer	3.59e-05	0.00267	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	3.57e-05	0.00266	CbGpPWpGaD
Fidaxomicin—Nausea—Doxorubicin—hematologic cancer	3.57e-05	0.000171	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—CASP8—hematologic cancer	3.42e-05	0.00255	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	3.41e-05	0.00254	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—S100A10—hematologic cancer	3.28e-05	0.00244	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	3.11e-05	0.00231	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	3.05e-05	0.00227	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	2.96e-05	0.00221	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—IFNG—hematologic cancer	2.91e-05	0.00217	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	2.9e-05	0.00216	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	2.89e-05	0.00215	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.86e-05	0.00213	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	2.79e-05	0.00208	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.71e-05	0.00202	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	2.7e-05	0.00201	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	2.7e-05	0.00201	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	2.68e-05	0.00199	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	2.6e-05	0.00193	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	2.6e-05	0.00193	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—IL1B—hematologic cancer	2.6e-05	0.00193	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CASP3—hematologic cancer	2.59e-05	0.00193	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—IL2—hematologic cancer	2.59e-05	0.00192	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	2.57e-05	0.00192	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	2.54e-05	0.00189	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.48e-05	0.00185	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.48e-05	0.00185	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.48e-05	0.00185	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	2.41e-05	0.0018	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	2.38e-05	0.00177	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	2.34e-05	0.00174	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	2.27e-05	0.00169	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.24e-05	0.00166	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GMPS—hematologic cancer	2.21e-05	0.00165	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PHYH—hematologic cancer	2.21e-05	0.00165	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—FTCD—hematologic cancer	2.21e-05	0.00165	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	2.2e-05	0.00164	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	2.19e-05	0.00163	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	2.04e-05	0.00152	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SMPD3—hematologic cancer	2.02e-05	0.00151	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	2.02e-05	0.0015	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.96e-05	0.00146	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.96e-05	0.00146	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1.93e-05	0.00144	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	1.93e-05	0.00143	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	1.92e-05	0.00143	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—TNF—hematologic cancer	1.88e-05	0.0014	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	1.87e-05	0.00139	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	1.87e-05	0.00139	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.8e-05	0.00134	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ASNS—hematologic cancer	1.77e-05	0.00132	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—DCK—hematologic cancer	1.77e-05	0.00132	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—B3GAT1—hematologic cancer	1.77e-05	0.00132	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1.73e-05	0.00128	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.69e-05	0.00126	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	1.69e-05	0.00126	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	1.68e-05	0.00125	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HDC—hematologic cancer	1.68e-05	0.00125	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.64e-05	0.00122	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.63e-05	0.00122	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.62e-05	0.00121	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.6e-05	0.00119	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.6e-05	0.00119	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CDA—hematologic cancer	1.53e-05	0.00114	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.53e-05	0.00114	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PC—hematologic cancer	1.48e-05	0.0011	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.45e-05	0.00108	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.43e-05	0.00106	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GBA—hematologic cancer	1.43e-05	0.00106	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.43e-05	0.00106	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.43e-05	0.00106	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—MTAP—hematologic cancer	1.3e-05	0.000972	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.3e-05	0.000971	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.28e-05	0.000951	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.24e-05	0.000926	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.24e-05	0.000924	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.2e-05	0.000896	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.2e-05	0.000894	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.2e-05	0.000891	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.17e-05	0.000874	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—FHL2—hematologic cancer	1.16e-05	0.000866	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.14e-05	0.000852	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—AGRN—hematologic cancer	1.14e-05	0.000849	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.11e-05	0.000829	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.08e-05	0.000807	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HMMR—hematologic cancer	1.08e-05	0.000805	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—IDH2—hematologic cancer	1.08e-05	0.000805	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.03e-05	0.000764	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ARNTL—hematologic cancer	1.02e-05	0.000757	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	9.98e-06	0.000743	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	9.95e-06	0.000741	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CA9—hematologic cancer	9.89e-06	0.000736	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ACP5—hematologic cancer	9.89e-06	0.000736	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NCOR2—hematologic cancer	9.76e-06	0.000727	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—IDH1—hematologic cancer	9.3e-06	0.000692	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	9.29e-06	0.000692	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	9.22e-06	0.000686	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTO1—hematologic cancer	9.19e-06	0.000685	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ABCC3—hematologic cancer	9.19e-06	0.000685	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—TXN—hematologic cancer	9.19e-06	0.000685	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SPHK1—hematologic cancer	9e-06	0.00067	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—UGT1A1—hematologic cancer	8.64e-06	0.000644	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	8.47e-06	0.000631	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CRABP1—hematologic cancer	8.41e-06	0.000626	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SLC22A1—hematologic cancer	8.41e-06	0.000626	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ALOX5—hematologic cancer	8.19e-06	0.00061	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	8.19e-06	0.00061	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NUP98—hematologic cancer	7.94e-06	0.000591	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NCOA3—hematologic cancer	7.7e-06	0.000574	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ADCY7—hematologic cancer	7.7e-06	0.000574	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NUP214—hematologic cancer	7.65e-06	0.00057	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ABCG2—hematologic cancer	7.49e-06	0.000558	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—MTR—hematologic cancer	7.49e-06	0.000558	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ENO2—hematologic cancer	7.35e-06	0.000547	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTT1—hematologic cancer	7.13e-06	0.000531	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SDC1—hematologic cancer	6.97e-06	0.000519	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.92e-06	0.000515	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.67e-06	0.000497	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	6.25e-06	0.000465	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NQO1—hematologic cancer	5.92e-06	0.000441	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CD44—hematologic cancer	5.92e-06	0.000441	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYCS—hematologic cancer	5.61e-06	0.000417	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	5.57e-06	0.000415	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTP1—hematologic cancer	4.94e-06	0.000368	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTM1—hematologic cancer	4.54e-06	0.000338	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NCOR1—hematologic cancer	4.54e-06	0.000338	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—MTHFR—hematologic cancer	4.01e-06	0.000299	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.37e-06	0.000251	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CREBBP—hematologic cancer	3.13e-06	0.000233	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.96e-06	0.000221	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ALB—hematologic cancer	2.93e-06	0.000218	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.8e-06	0.000208	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.58e-06	0.000192	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PTEN—hematologic cancer	2.23e-06	0.000166	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—EP300—hematologic cancer	2.13e-06	0.000159	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.57e-06	0.000117	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—AKT1—hematologic cancer	1.29e-06	9.58e-05	CbGpPWpGaD
